Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of MVI 100 for Cervical Ripening
NCT00528255Phase 2Withdrawn
- Sponsor
- Ferring Pharmaceuticals
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of misoprostol in cervical ripening (CR), sponsored by Ferring Pharmaceuticals. Status: withdrawn.
02
Drugs
misoprostol
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on NCT00528255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528255.